Application Process FAQs
In order to be eligible for a Histiocytosis Association grant, an applicant must be a full-time faculty member at an academic institution.
The Histiocytosis Association grant program is open to all projects, both in the United States and Internationally. We seek to fund the most cutting edge research, no matter the location of the project, as long it meets our terms and conditions and is a full-time faculty member at an academic institution.
Interested applicants can submit a proposal beginning in early April until June 11, 2023. During this time, all interested applicants can go to www.histio.org/RFRP and create a username and password. Your username and password should be kept in a secure place since you will be able to log in at any time to review the status of your application. After registering, applicants will have access to the online application. Applicants will be asked to provide the following information:
- primary and secondary investigator contact information
- project title
- amount of funding requested
- what disease the project pertains to
- how the project is relevant to histiocytic disorders
- how histiocytosis patients will benefit from the project
- how the grant will impact long-term research funding for the project
- the anticipated start date of the project
- an uploaded research proposal for review
Once a proposal is submitted, no changes can be made to the form. Applications will enter the processing and review session shortly after the June 1 deadline. Applicants will be notified via email after December 15 if their proposal has been accepted for funding. Funding is awarded by December 31 pending signed agreements.
In rare circumstances, the funding period may be extended upon consultation with the Association's Scientific Committee for approval.
The application deadline will NOT be extended individually for any reason. This includes but is not limited to: special individual circumstances, U.S. or International holidays and meetings or conventions which coincide with the deadline date. Applicants are given approximately 45 days to submit a request for research proposal and should plan accordingly.
Grant applications face an extensive evaluation and peer review process, modeled after that used by the US National Institutes of Health (NIH). This process ensures an impartial and transparent approach to grant funding through “a process that is fair, equitable, timely, and conducted in a manner free of bias.” The initial grant review is conducted by the Histiocyte Society’s Scientific Committee. The Society’s Scientific Committee reviews and scores the research grant applications received by the Association based on scientific merit, relevance and feasibility. A secondary review is performed by the medical professionals on Histiocytosis Association Board of Trustees. For complete information and criteria used to review applications, please visit the Annual Funding Process webpage.
The funding level for the Research Grant applications is up to $50,000. Any grants requesting funding in excess of $50,000 will not be considered for the grant cycle.
Yes, the Histiocytosis Association will not fund overhead costs, travel budgets or principal investigator salaries.
Please review our Terms and Conditions for detailed information.
Grant proposals will only be accepted by creating a grant application account on www.histio.org/RFRP from mid-April to June 11. Once an account has been created, applicants will be asked to fill out an application form and upload a research proposal. The grant application area of the Histiocytosis Association website is the only location that a grant proposal can be submitted. Emailed, faxed, and paper mailing are not accepted.
Research grants are awarded for a one-year term beginning on December 31. Proposals that require longer than one-year are not subject to review and will be disqualified.
Should an awarded project need unexpected additional time beyond one-year, a request may be made for consideration prior to the due date of the annual reports. Extension of funding is not guaranteed and may affect future grant proposals.
Narrative Biographies (also listed as a bibliographical sketch) should include, at a minimum:
- where the applicant studied
- their current job title and place of employment
- area(s) of focus and any recent research
- if you have a direct connection working with histiocytosis, please indicate so.
Both. Please indicate any grants within the last five years that have provided funding for the current project you are requesting the Histiocytosis Association Research Grant to fund. Also indicate which grants you applied for within a five-year period, funded and unfunded.
Please include all grant information in which you played an important role, this includes Principal Investigator, Secondary Investigator, Co-Principal Investigator and Sub-Principal Investigator.
Principal Investigators may submit only one application for funding as the Principal Investigator. However, a Principal Investigator may be listed as a Secondary Investigator on a second grant application. Secondary Investigators may be listed on more than one application.
Administrative Assistants applying for different Principal/Primary Investigators may use the same account to submit multiple applications. Please note that all notifications will be sent to the email used in the account profile, not the individual applications.
Having this information helps facilitate the contract procedures should your project be awarded a grant. This information is also used to secure required reports should we be unable to obtain them from the Principal Investigator directly.
Questions can be submitted to the Research Grants Administrator at email@example.com or call +1-856-589-6606.
Dates are meant to give a general idea of the grant cycle timeline and are subject to change at any time without notice.
Applications Accepted Online: Grants open on or about on April 17 and close on June 11
Processing and Scientific Committee Review Session: Early June- September
Processing and Histiocytosis Association Board Secondary Review Session: September – Early December
Notice of Award: on or about December 15
Funding Awarded: by December 31
12 Month Report due for awarded applicants: January 30
Funding & Reports FAQs
In January, after the close of the funding year, a written 12-month scientific conclusion, layperson and financial report will be due to the Association. The scientific conclusion report will contain the project's final conclusion as well as the financial report providing a brief budget detailing the expenditure of grant awarded funds. The budget should address and match the budget submitted with the original application for funding. The layperson final report should include an overview of the project, along with a final conclusion in layperson terms, which will be published on the Histiocytosis Association’s website. Please note: if reports are not submitted on time or arrangements made for extensions, funding may be forfeited and required to be returned.
Applicants who are awarded grant funds are required to submit the requested 12-month reports. As well as:
- ensure all results and findings are made public and that the Histiocytosis Association's support is acknowledged in any published materials and/or publications
- submit a copy of each publication and/or presentation to the Association so it can be acknowledged on its website
- submit a written abstract to the Association for presentation at an Annual Meeting of the Histiocyte Society
- for Grant awardees located in the United States, a W-9 is required for submission from the institution where the research is being conducted.
Any requests to make changes to the original intent, timing or budget for the project after funding has been awarded must be submitted in writing and emailed to firstname.lastname@example.org.
Information regarding requirements for reporting will be sent to awardees 3-4 weeks prior to the report due date. Please note: if reports are not submitted on time or arrangements made for extensions, funding may be forfeited and requested to be returned.
Twelve-month scientific conclusion report: This detailed report contains the project’s final conclusion, including any relative charts, graphs, or images. It will be distributed to the Association Board of Trustees for review.
Twelve-month layperson final report: The layperson report will be posted online via the Association's website and digital communications. This report should include an overview of the project's results and how it will affect the Histio Community in layman's terms.
Financial Report: This report should detail the expenditure of grant funds. It will be distributed to the Association Board of Trustees for review and compliance to our terms and conditions for grants. Financial Reports should address the same budget lines proposed in the original grant application.
Institutions should retain all receipts for a minimum of three (3) years. In the event of an audit, any expenses in which receipts cannot be produced may require repayment of funds. Receipts are should not be included in the financial report.
If 12-month reports are not submitted on time, the Histiocytosis Association may require the Primary Investigator and his/her institution return the funding as per the funding agreement signed by both parties. If you are unable to submit these reports when they are due, it is expected that you email email@example.com with an explanation and request for extension at least one (1) week prior to the due date.
Yes. Institutions should retain receipts for at least three (3) years in case a financial audit is required and receipts must be produced. Institutions may be required to return any funds for which receipts cannot be produced should an audit occur.
No. The Histiocytosis Association will award funding to the Primary Investigator’s institution. It is up to that institution to disburse any funding for joint projects. The Primary Investigator is also responsible for submitting all required reports on-time.
Research grant applications and investigator information are acquired through a secure system provided by WizeHive, Inc., an online grants management company. Applications and information are stored on a secure, password protected server and not shared with the public unless a grant is awarded, at which time select information will be shared. Reviewers, administrators and our Board of Trustees access applications solely for the reviewing and awarding determination process. Should your application be awarded a grant, the lay summary information will be made public via traditional and digital media. The applicant retains ownership of intellectual property contained in the application, however, by submitting an application, provides consent and a worldwide, royalty-free license for the Histiocytosis Association to share the title, subject matter, lay summary, investigator and institution information, and subsequent required 6 and 12 month reports with its Board of Trustees and the public, in full or in part. Grantees should make reasonable effort to have results of their research published in industry journals and submit an Abstract application for presentation at the next year's Histiocyte Society Annual Meeting.